» Articles » PMID: 21932365

Neutral Sphingomyelinase Activation Precedes NADPH Oxidase-dependent Damage in Neurons Exposed to the Proinflammatory Cytokine Tumor Necrosis Factor-α

Overview
Journal J Neurosci Res
Specialty Neurology
Date 2011 Sep 21
PMID 21932365
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammation accompanied by severe oxidative stress plays a vital role in the orchestration and progression of neurodegeneration prevalent in chronic and acute central nervous system pathologies as well as in aging. The proinflammatory cytokine tumor necrosis factor-α (TNFα) elicits the formation of the bioactive ceramide by stimulating the hydrolysis of the membrane lipid sphingomyelin by sphingomyelinase activities. Ceramide stimulates the formation of reactive oxygen species (ROS) and apoptotic mechanisms in both neurons and nonneuronal cells, establishing a link between sphingolipid metabolism and oxidative stress. We demonstrated in SH-SY5Y human neuroblastoma cells and primary cortical neurons that TNFα is a potent stimulator of Mg(2+) -dependent neutral sphingomyelinase (Mg(2+) -nSMase) activity, and sphingomyelin hydrolysis, rather than de novo synthesis, was the predominant source of ceramide increases. Mg(2+) -nSMase activity preceded an accumulation of ROS by a neuronal NADPH oxidase (NOX). Notably, TNFα provoked an NOX-dependent oxidative damage to sphingosine kinase-1, which generates sphingosine-1-phosphate, a ceramide metabolite associated with neurite outgrowth. Indeed, ceramide and ROS inhibited neurite outgrowth of dorsal root ganglion neurons by disrupting growth cone motility. Blunting ceramide and ROS formation both rescued sphingosine kinase-1 activity and neurite outgrowth. Our studies suggest that TNFα-mediated activation of Mg(2+) -nSMase and NOX in neuronal cells not only produced the neurotoxic intermediates ceramide and ROS but also directly antagonized neuronal survival mechanisms, thus accelerating neurodegeneration.

Citing Articles

Alaska's Flora as a Treatment for Cancer.

Papakotsi V, Murphy A, Vagts M, Arsenault E, McGill C, Barth B Int J Biopharm Sci. 2025; 2(2).

PMID: 39877830 PMC: 11774448.


Obesity Promotes the Ceramide-Mediated NADPH Oxidase in Acute Myeloid Leukemia.

Wang W, Sabol R, Day A, Hathorn T, Clark M, Connell S J Blood Disord Malig. 2024; 2(1).

PMID: 39364061 PMC: 11449433.


Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy.

Sukocheva O, Neganova M, Aleksandrova Y, Burcher J, Chugunova E, Fan R Cell Commun Signal. 2024; 22(1):251.

PMID: 38698424 PMC: 11064425. DOI: 10.1186/s12964-024-01626-6.


Sphingolipid metabolism in brain insulin resistance and neurological diseases.

Mei M, Liu M, Mei Y, Zhao J, Li Y Front Endocrinol (Lausanne). 2023; 14:1243132.

PMID: 37867511 PMC: 10587683. DOI: 10.3389/fendo.2023.1243132.


A Comprehensive Review on the Interplay between spp. and Host Sphingolipid Metabolites.

Peters S, Fohmann I, Rudel T, Schubert-Unkmeir A Cells. 2021; 10(11).

PMID: 34831424 PMC: 8623382. DOI: 10.3390/cells10113201.


References
1.
Chalfant C, Spiegel S . Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. J Cell Sci. 2005; 118(Pt 20):4605-12. DOI: 10.1242/jcs.02637. View

2.
Barth B, Stewart-Smeets S, Kuhn T . Proinflammatory cytokines provoke oxidative damage to actin in neuronal cells mediated by Rac1 and NADPH oxidase. Mol Cell Neurosci. 2009; 41(2):274-85. PMC: 2693287. DOI: 10.1016/j.mcn.2009.03.007. View

3.
Clarke C, Snook C, Tani M, Matmati N, Marchesini N, Hannun Y . The extended family of neutral sphingomyelinases. Biochemistry. 2006; 45(38):11247-56. DOI: 10.1021/bi061307z. View

4.
Bedard K, Krause K . The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007; 87(1):245-313. DOI: 10.1152/physrev.00044.2005. View

5.
Hannun Y, Luberto C . Ceramide in the eukaryotic stress response. Trends Cell Biol. 2000; 10(2):73-80. DOI: 10.1016/s0962-8924(99)01694-3. View